0000899243-21-016131.txt : 20210416
0000899243-21-016131.hdr.sgml : 20210416
20210416192036
ACCESSION NUMBER: 0000899243-21-016131
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210414
FILED AS OF DATE: 20210416
DATE AS OF CHANGE: 20210416
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Troendle August J.
CENTRAL INDEX KEY: 0001622058
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37856
FILM NUMBER: 21832701
MAIL ADDRESS:
STREET 1: 5375 MEDPACE WAY
CITY: CINCINNATI
STATE: OH
ZIP: 45227
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medpace Holdings, Inc.
CENTRAL INDEX KEY: 0001668397
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 320434904
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5375 MEDPACE WAY
CITY: CINCINNATI
STATE: OH
ZIP: 45227
BUSINESS PHONE: (513) 579-9911
MAIL ADDRESS:
STREET 1: 5375 MEDPACE WAY
CITY: CINCINNATI
STATE: OH
ZIP: 45227
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-14
0
0001668397
Medpace Holdings, Inc.
MEDP
0001622058
Troendle August J.
C/O MEDPACE HOLDINGS, INC.
5375 MEDPACE WAY
CINCINNATI
OH
45227
1
1
1
0
President & CEO
Common Stock
2021-04-14
4
S
0
3720
180.48
D
6453482
I
By Medpace Investors, LLC
Common Stock
2021-04-15
4
S
0
31270
186.65
D
6422212
I
By Medpace Investors, LLC
Common Stock
2021-04-16
4
S
0
17528
180.30
D
6404684
I
By Medpace Investors, LLC
Common Stock
706643
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 12, 2021.
The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $181.55. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.045 to $190.60. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $184.91. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
/s/ Stephen P. Ewald, Attorney-in-Fact for August J. Troendle
2021-04-16